Slinda and Migraine with Aura: Contraindication
Slinda (drospirenone 4mg) is absolutely contraindicated in women with migraine with aura due to the significantly increased risk of ischemic stroke when combined hormonal contraceptives containing estrogen are used in this population. 1
Understanding the Contraindication
Why Combined Hormonal Contraceptives Are Prohibited
- Women with migraine with aura have a significantly elevated baseline risk of ischemic stroke compared to those without aura. 1
- The American College of Obstetricians and Gynecologists and the American Headache Society explicitly state that combined hormonal contraceptives are contraindicated in women with migraine with aura due to this compounded stroke risk. 1
- Combined hormonal contraception with estrogens significantly increases the risk of stroke in women with migraine with aura. 2
Important Clinical Distinction
However, Slinda is a progestin-only pill (drospirenone 4mg monotherapy) without estrogen, which changes the risk profile:
- The contraindication for combined hormonal contraceptives specifically relates to estrogen-containing formulations. 1, 2
- Progestin-only contraceptives are generally considered safe alternatives for women with migraine with aura because they do not carry the same stroke risk as estrogen-containing products.
Recommended Contraceptive Approach
Safe Contraceptive Options for Migraine with Aura
- Progestin-only methods (including progestin-only pills like Slinda) are appropriate alternatives when combined hormonal contraceptives are contraindicated. 1
- Other safe options include progestin-only implants, injections, and intrauterine devices.
What to Avoid
- All combined hormonal contraceptives (pills, patches, rings) containing estrogen must be avoided in women with migraine with aura. 1
- This prohibition applies even to women with pure menstrual migraine if they experience aura symptoms. 1
Managing Migraine with Aura Itself
Acute Treatment Strategy
- Start NSAIDs (ibuprofen, naproxen, diclofenac) or aspirin as soon as possible during the aura phase to prevent or diminish the subsequent headache. 3, 4, 2
- If NSAIDs fail, use triptans when the headache begins—but not during the aura phase itself. 1, 2
Preventive Treatment Options
- First-line preventive medications include propranolol (80-160 mg daily), metoprolol (50-100 mg twice daily or 200 mg modified-release once daily), or topiramate (50-100 mg daily). 1
- These preventive treatments are the same as those used for migraine without aura, as there are very few randomized trials specifically dedicated to migraine with aura. 2
Critical Monitoring Points
- Evaluate treatment response within 2-3 months after initiation using headache calendars to track attack frequency, severity, and medication use. 1
- Watch for medication overuse headache, which can develop from using acute medications more than twice weekly. 3, 4
- If aura symptoms change character (longer duration >1 hour, sudden onset, symptoms in a vascular territory), urgent evaluation for TIA or stroke is necessary. 2